2021 GLOBAL FINALIST
Phagomed Biopharma
Digital Health
Novel anti-bacterials are urgently needed. Humanity faces a monumental crisis due to increasing antibiotic resistance. As a solution, PhagoMed has created a synthetic biology platform called the LysinBuilder that uses prediction algorithms to design novel precision anti-bacterials that work where antibiotics fail and enable new treatment paradigms.
📌 HQ: Vienna, Austria